Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e73-e74. doi: 10.1111/jdv.13733. Epub 2016 Jun 3.

Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.

Author information

1
Dermatology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
2
Pathology, Université Paul-Sabatier-Toulouse III and Institut Universitaire du Cancer de Toulouse, Toulouse, France.
3
INSERM UMR 1037-CRCT, Toulouse, France.
PMID:
27256718
DOI:
10.1111/jdv.13733
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center